Symbollon Pharma Cash Flow - Annual (OTCMKTS:SYMBA)

Add to My Stocks
$0 $0 (0%) SYMBA stock closing price Aug 25, 2014 (Closing)

The financial analysis of SYMBA requires an investor to check the cash flows for Symbollon Pharma. The profit-loss statement shows Symbollon Pharma profits, the balance sheet shows Symbollon Pharma debt, and the cash flow statement reflects the liquidity and solvency of a firm. This statement reflects the company's ability to generate cash flows. Items like capital purchases, bank loan payments etc. which have a direct impact on the cash position of a company come out through the statemement of cash flows and help an investor who undertakes the Symbollon Pharma stock analysis. Symbollon Pharma generated $-0.22M cash from operating activities in 2010. The cash from operating activities for Symbollon Pharma is $ 2010, which saw a decrease from previous year.

View details of Symbollon Pharma cash flows for latest & last 10 financial years
show more
Fiscal year is Jan - Dec201020092008
Net Income Cash Flow
-0.44M-0.69M-1.78M
Depreciation Depletion Amortization Cash-Flow---
Net Increase (Decrease) in Assets Liabilities---0.23M
Cash From (used in) Discontinued Operations---
Other Adjustments Net---
Net Cash from (used by) Operating Activities
-0.22M-0.07M-1.01M
Increase (Decrease) in Prop Plant And Equipment---
Acquisition Disposition of Subsidiaires---
Increase (Decrease) in Investments---
Other Cash Inflow (Outflow) from Investment Activities---0.01M
Net Cash from (used by) Investment Activities
---0.01M
Issuance (Purchase) of Equity Shares---
Issuance (Repayment) of Debt Securities---
Increase (Decrease) in Bank & Other Borrowings---
Payment of Dividends & Other Cash Distributions---
Other Cash from (used by) Financing Activities---
Net Cash from (used by) Financing Activities
---
Effect of Exchange Rate Changes on Cash---
Net Change in Cash & Cash Equivalents
--0.05M-1.03M
Cash & Equivalents at Beginning of Year--1.1M
Cash & Equivalents at Year End---
All figures in USD. M: Millions of USD, B: Billions of USD.

The statement of cash flows comprises of cash flow from financing, cash flow from operations and cash flow from investing activities. All the three can have an impact on the stock price. The Symbollon Pharma stock price history and Symbollon Pharma stock comparison chart inevitably reflect its cash flow situation.

  • Symbollon Pharma had a Net Change in Cash and Cash Equivalents of $- for the latest year 2010. If a firm is able to grow its cash, it is considered to be a positive signal and could lead to a jump in the Symbollon Pharma stock price, albeit too much cash on hand can imply the company has no or limited avenues for growth in which to invest this cash.
  • Cash Flow from operating activities: Symbollon Pharma reported a negative operating cash flow of $-0.22M for 2010 and has seen a decrease from the previous year. Operating cash flow comes from main business activities. Investors look for positive cash flow from recurring operating activities.
  • Cash from investing stood at a negative value of $- for SYMBA stock. A company with surplus cash usually thinks of re-investing it in the form of buying fixed assests, or purchasing plant/ machinery which will help grow the business further. By looking at cash flow from investment activities one can check where the company is putting its cash.
  • Cash Flow from financing activities: Financing activities include the cash that comes into a company in the form of loans or interest earned or shareholders money, as well as the cash that goes out. Symbollon Pharma spent $- from financing activities, in the form of repayment of loans or interest paid, dividend pay-out to shareholders etc.

Annual Cash Flow Statements For Symbollon Pharmaceuticals, Inc. Peers

Applied Neurosolutions cash flow, Taxus Cardium Pharma cash flow, Hemispherx BioPharma cash flow